Sigachi Industries Ltd
Incorporated in 1989, Sigachi Industries Ltd is a manufacturing and selling of MCC.[1]
- Market Cap ₹ 1,217 Cr.
- Current Price ₹ 31.8
- High / Low ₹ 60.5 / 30.5
- Stock P/E 20.2
- Book Value ₹ 14.6
- Dividend Yield 0.31 %
- ROCE 13.4 %
- ROE 9.83 %
- Face Value ₹ 1.00
Pros
- Company is expected to give good quarter
Cons
- Company has a low return on equity of 12.2% over last 3 years.
- Promoters have pledged or encumbered 45.4% of their holding.
- Dividend payout has been low at 5.13% of profits over last 3 years
- Promoter holding has decreased over last 3 years: -4.34%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Part of BSE Healthcare BSE SmallCap BSE Allcap
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|
74 | 81 | 102 | 128 | 139 | 188 | 249 | 290 | 318 | 408 | 439 | |
64 | 72 | 89 | 101 | 114 | 151 | 199 | 234 | 258 | 334 | 357 | |
Operating Profit | 10 | 9 | 12 | 27 | 25 | 37 | 50 | 56 | 59 | 74 | 82 |
OPM % | 13% | 11% | 12% | 21% | 18% | 20% | 20% | 19% | 19% | 18% | 19% |
0 | 1 | 3 | 4 | 5 | 3 | 3 | 7 | 12 | 20 | -99 | |
Interest | 4 | 4 | 4 | 3 | 2 | 1 | 1 | 4 | 7 | 11 | 10 |
Depreciation | 1 | 1 | 1 | 2 | 2 | 2 | 3 | 7 | 9 | 13 | 14 |
Profit before tax | 5 | 4 | 10 | 25 | 25 | 37 | 49 | 52 | 55 | 71 | -41 |
Tax % | 27% | 33% | 26% | 23% | 20% | 22% | 22% | 19% | 26% | 33% | |
3 | 3 | 8 | 20 | 20 | 29 | 38 | 42 | 41 | 48 | -61 | |
EPS in Rs | 1.15 | 0.92 | 2.52 | 6.41 | 2.66 | 3.78 | 1.24 | 1.35 | 1.25 | 1.25 | -1.47 |
Dividend Payout % | 9% | 11% | 4% | 2% | 4% | -0% | 8% | 7% | 8% | -0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 24% |
3 Years: | 18% |
TTM: | 37% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 18% |
3 Years: | 8% |
TTM: | 50% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 2% |
1 Year: | -45% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 15% |
3 Years: | 12% |
Last Year: | 10% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3 | 3 | 3 | 3 | 8 | 8 | 31 | 31 | 33 | 38 |
Reserves | 15 | 17 | 24 | 43 | 59 | 87 | 196 | 235 | 377 | 521 |
22 | 28 | 29 | 24 | 28 | 21 | 35 | 68 | 135 | 113 | |
16 | 12 | 15 | 21 | 14 | 18 | 22 | 35 | 64 | 74 | |
Total Liabilities | 56 | 60 | 71 | 91 | 109 | 134 | 284 | 369 | 609 | 746 |
23 | 23 | 26 | 29 | 32 | 38 | 53 | 122 | 139 | 254 | |
CWIP | -0 | 1 | 1 | 2 | 3 | 4 | 10 | 35 | 91 | 5 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 102 | 102 |
33 | 36 | 45 | 60 | 74 | 92 | 221 | 210 | 276 | 385 | |
Total Assets | 56 | 60 | 71 | 91 | 109 | 134 | 284 | 369 | 609 | 746 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|
9 | 7 | 15 | 12 | 28 | 5 | 28 | 15 | 36 | ||
-2 | -4 | -6 | -7 | -11 | -63 | -93 | -158 | -90 | ||
-6 | -4 | -9 | 3 | -9 | 108 | 26 | 163 | 70 | ||
Net Cash Flow | 1 | -1 | -0 | 8 | 8 | 51 | -39 | 20 | 15 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 66 | 60 | 79 | 72 | 79 | 82 | 106 | 115 | 126 | 120 |
Inventory Days | 126 | 136 | 88 | 118 | 130 | 57 | 49 | 89 | 77 | 71 |
Days Payable | 103 | 61 | 50 | 45 | 37 | 29 | 28 | 54 | 69 | 61 |
Cash Conversion Cycle | 89 | 136 | 116 | 145 | 172 | 109 | 126 | 150 | 135 | 130 |
Working Capital Days | -1 | -7 | 10 | 48 | 65 | 73 | 86 | 87 | 66 | 96 |
ROCE % | 19% | 27% | 46% | 33% | 36% | 27% | 19% | 14% | 13% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 14h
-
Record Date For The Purpose Of Dividend
1d - Record date Sept 16, 2025; books closed Sept 17–23 for final dividend and 36th AGM.
-
Business Responsibility and Sustainability Reporting (BRSR)
1d - Filed BRSR for FY2024-25 detailing operations, ESG targets, locations, employees, and metrics.
-
Annual General Meeting On 23-09-2025
1d - Annual Report FY2024-25 and Notice of 36th AGM on 23 Sep 2025 (VC/OAVM); report link provided.
- Reg. 34 (1) Annual Report. 1d
Annual reports
Concalls
-
Aug 2025Transcript PPT REC
-
Jun 2025Transcript PPT REC
-
Jan 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
Jun 2024Transcript PPT REC
-
Jan 2024Transcript PPT REC
-
Nov 2023Transcript PPT
-
Nov 2023TranscriptPPT
-
Aug 2023TranscriptNotesPPT
-
Aug 2023TranscriptNotesPPT
-
May 2023TranscriptNotesPPT REC
-
Feb 2023TranscriptPPT
-
Feb 2023Transcript PPT
-
Jan 2023TranscriptNotesPPT
-
Dec 2022TranscriptNotesPPT
-
Nov 2022Transcript PPT
-
Aug 2022TranscriptNotesPPT
-
Jul 2022Transcript PPT
-
May 2022Transcript PPT
Business Overview:[1][2][3]
SIL is one of the largest manufacturers of Cellulose based excipients. The company manufactures MCC in 60 distinct grades ranging from 15 microns to 250 microns. With over 60+ products, the company is in the business of:
a) Active Pharmaceutical Ingredients
b) Intermediates
c) Pharmaceutical Excipients
d) Vitamin-mineral blends
e) Polymer blends
f) Food & Nutrition
g) Operations and Management services